Transcranial Direct Current Stimulation for the Treatment of Deficits After Traumatic Brain Injury
NCT ID: NCT02613936
Last Updated: 2023-10-06
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
40 participants
INTERVENTIONAL
2015-09-30
2022-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
tDCS as Adjunctive Therapy to Cognitive Stimulation in Medical Students With Depression
NCT06562387
Transcranial Direct Current Stimulation in Major Depression
NCT03556124
Transcranial Direct Current Stimulation (tDCS) Therapy in Major Depression
NCT04507243
Transcranial Direct Current Stimulation in Patients With Disorders of Consciousness
NCT01673126
High-Definition Transcranial Direct Current Stimulation (HD-tDCS) for Sensory Deficits in Complex Traumatic Brain Injury
NCT03799458
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Specific Aim 1: tDCS for executive dysfunction in mmTBI Experiments in this aim will test the hypothesis that in patients with mmTBI, left prefrontal anodal tDCS concurrent with cognitive training for ten consecutive weekdays will result in significantly more improvement in executive function compared to sham stimulation. Patients with cognitive complaints 3 months to 2 years after mmTBI will be recruited from local emergency departments and brain injury clinics. Aim 1.1: tDCS will be paired with computer-based cognitive training tasks of response inhibition, set shifting, and working memory, while executive function will be measured with the NIH Examiner battery before, immediately after, and one month after stimulation. Aim 1.2: Persistence of post-traumatic symptom reduction and quality of life improvement will be assessed with Common Data Elements instruments via telephone interview at 6 months and one year. Aim 1.3: Clinical predictors of tDCS response including injury severity, premorbid intelligence, and post-traumatic symptom burden will be determined with linear mixed-models analysis.
Specific Aim 2: tDCS for depressive symptoms in mmTBI Experiments in this aim will test the hypothesis that left prefrontal anodal tDCS in patients with mmTBI will significantly reduce depressive symptoms compared to sham stimulation. Aim 2.1: Patients will be assessed for symptoms of depression via self-report instruments and clinician-administered scales from NIH Common Data Elements before, immediately after, and one month after the stimulation protocol. Aim 2.2: Persistence of antidepressant benefit will be assessed via telephone interview at 6 months and one year. Aim 2.3: clinical predictors of tDCS response such as injury severity, premorbid intelligence, and symptom burden will be determined.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active anodal tDCS + cognitive training
In this arm, patients with mmTBI will undergo 10 sessions of active tDCS x 30 minutes combined with simultaneous cognitive training on consecutive weekdays.
Anodal tDCS
Anodal tDCS lowers neuronal membrane potentials, leading to increased probability of depolarization from incoming stimuli.
Cognitive training
Cognitive training involves solving executive function tasks on a computer.
Placebo anodal tDCS + cognitive training
In this arm, patients with mmTBI will undergo 10 sessions of placebo tDCS x 30 minutes combined with simultaneous cognitive training on consecutive weekdays.
Cognitive training
Cognitive training involves solving executive function tasks on a computer.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Anodal tDCS
Anodal tDCS lowers neuronal membrane potentials, leading to increased probability of depolarization from incoming stimuli.
Cognitive training
Cognitive training involves solving executive function tasks on a computer.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. TBI with + loss of consciousness (LOC) less than 24 hours
3. injured between 3 months and 5 years ago
4. Glasgow Coma Score (GCS) between 9 and 15 upon emergency department (ED) admission
5. less than 1 week of post-traumatic amnesia (PTA)
6. 1 out of 4 cognitive symptoms on the Neurobehavioral Symptom Inventory (NSI)
Exclusion Criteria
2. history of psychosis
3. history of recent substance dependence (past 2 years)
4. any skull defect
5. presence of any implanted electrical device
6. recent medical instability (within 3 weeks)
7. pregnancy
8. appointment of a legal representative.
18 Years
55 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institutes of Health (NIH)
NIH
National Institute of General Medical Sciences (NIGMS)
NIH
University of New Mexico
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
William Shuttleworth, PhD
Role: PRINCIPAL_INVESTIGATOR
UNM Center for Brain Recovery and Repair
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UNM Center for Brain Recovery and Repair
Albuquerque, New Mexico, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Document Type: Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
For interested volunteers please visit this webpage for contact information to enroll.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UNM HRRC #15-124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.